QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 2, 2005, 25(44):10252-10261; doi:10.1523/JNEUROSCI.3348-05.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Chiba, T. Articles by Matsuoka, M. Search for Related Content PubMed PubMed Citation Articles by Chiba, T. Articles by Matsuoka, M.

 Previous Article  |  Next Article 

Neurobiology of Disease
Development of a Femtomolar-Acting Humanin Derivative Named Colivelin by Attaching Activity-Dependent Neurotrophic Factor to Its N Terminus: Characterization of Colivelin-Mediated Neuroprotection against Alzheimer's Disease-Relevant Insults In Vitro and In Vivo

Tomohiro Chiba,^1 * Marina Yamada,^1,2 * Yuichi Hashimoto,¹ Maiko Sato,¹ Jumpei Sasabe,^1,2 Yoshiko Kita,¹ Kenzo Terashita,¹ Sadakazu Aiso,² Ikuo Nishimoto,¹ and Masaaki Matsuoka¹

Departments of ¹Pharmacology and ²Anatomy, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan

Alzheimer's disease (AD) is the most common cause of dementia. Humanin (HN) is a short bioactive peptide abolishing neuronal cell death induced by various familial AD (FAD)-causative genes and amyloid- (A) in vitro. It has been shown that HN suppresses memory impairment of mice induced by intracerebroventricular administration of A. To potentiate the neuroprotective effect of HN, we synthesized a hybrid peptide named Colivelin composed of activity-dependent neurotrophic factor (ADNF) C-terminally fused to AGA-(C8R)HNG17, a potent HN derivative. Colivelin completely suppresses death induced by overexpressed FAD-causative genes and A1-43 at a concentration of 100 fM, whereas AGA-(C8R)HNG17 does so at a concentration of 10 pM. Colivelin-induced neuroprotection has been confirmed to occur via two neuroprotective pathways: one mediated by Ca²⁺/calmodulin-dependent protein kinase IV, triggered by ADNF, and one mediated by signal transducer and activator of transcription 3, triggered by HN. In vivo animal studies have further indicated that intracerebroventricular administration of Colivelin not only completely suppresses impairment in spatial working memory induced by repetitive intracerebroventricular injection of A25-35 or A1-42, but also it antagonizes neuronal loss in the CA1 region of hippocampus induced by hippocampal injection of A1-42. In addition, intraperitoneally administered Colivelin suppresses memory impairment caused by a muscarinic acetylcholine receptor antagonist, 3-quinuclidinyl benzilate, indicating that a substantial portion of intraperitoneally administered Colivelin passes through the blood-brain barrier and suppresses functional memory deficit. Thus, Colivelin might serve as a novel drug candidate for treatment of AD.

Key words: Alzheimer's disease; APP; A; ADNF; Humanin; Colivelin

---

Received May 20, 2005; revised September 20, 2005; accepted September 23, 2005.

This article has been cited by other articles:

				Y. Hashimoto, M. Kurita, S. Aiso, I. Nishimoto, and M. Matsuoka Humanin Inhibits Neuronal Cell Death by Interacting with a Cytokine Receptor Complex or Complexes Involving CNTF Receptor {alpha}/WSX-1/gp130 Mol. Biol. Cell, June 15, 2009; 20(12): 2864 - 2873. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help